NKTR logo

Nektar Therapeutics (NKTR)

Profile

Full Name

Nektar Therapeutics

Ticker Symbol

NKTR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 3, 1994

Indexes

Not included

Website

http://www.nektar.com

Employees

61

Key Details

Price

$0.60(-3.18%)

Market cap

$111.72M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$98.43M(+9.22% YoY)

Annual EPS

-$0.58(+60.00% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.60
NKTR price is $0.60

30-Day Relative Volume

1.25
NKTR 30-day relative volume is 1.25

Price Performance

Price Today change

-3.18%
NKTR price is down -3.18% today

Price YTD change

-35.45%
NKTR price is down -35.45% since January 1st

Price 1-year change

-64.05%
NKTR price is down -64.05% year-on-year

Price 3-year change

-90.25%
NKTR price is down -90.25% over the past 3 years

Price Range

Price All-time high

$111.36
NKTR price is currently -99.46% below its historical high of $111.36

Price 3-year low

$0.41
NKTR price is currently +46.41% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$111.72M
NKTR market capitalization is $111.72 million

Market cap 3-year change

-90.26%
NKTR market capitalization is down -90.26% over the past 3 years

Market cap All-time high

$17.83B
NKTR market capitalization is currently -99.37% below its historical high of $17.83 billion

Market cap sector rank

49.79%
NKTR market capitalization is higher than 49.79% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.35%
NKTR shares outstanding is up +1.35% year-on-year

Shares Outstanding 3-Year Change

-0.09%
NKTR shares outstanding is down -0.09% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.43
NKTR beta is 1.43

200-day SMA

$1.09
NKTR price is currently -44.77% below its 200-day simple moving average

50-day SMA

$0.78
NKTR price is currently -23.41% below its 50-day simple moving average

RSI

41.71
NKTR 14-day relative strength index is 41.71

Volume

1.25
NKTR 30-day relative volume is 1.25

ATR

$0.09
NKTR average true range is $0.09

10-day Historical Volatility

164.00%
NKTR 10-day historical volatility is 164.00%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$98.43M
NKTR annual revenue is $98.43 million

Revenue Analysts estimate

$63.85M
NKTR annual revenue is currently +54.16% higher than the consensus analysts' forecast

Revenue 1-year change

+9.22%
NKTR annual revenue is up +9.22% year-on-year

Revenue Sector rank

56.22%
NKTR annual revenue is higher than 56.22% of companies in Healthcare sector

EPS

EPS

-$0.58
NKTR annual earnings per share is -$0.58

EPS Analysts estimate

-$0.72
NKTR annual earnings per share is currently -19.11% lower than the consensus analysts' forecast

EPS 1-year change

+60%
NKTR annual earnings per share is up +60% year-on-year

EPS Sector rank

65.73%
NKTR annual earnings per share is higher than 65.73% of companies in Healthcare sector

Profit

Gross profit

$67.74M
NKTR annual gross profit is $67.74 million

Gross margin

68.82%
NKTR annual gross profit margin is 68.82%

Operating profit

-$129.92M
NKTR annual operating income is -$129.92 million

Operating margin

-131.99%
NKTR annual operating profit margin is -131.99%

Net income

-$118.96M
NKTR annual net profit is -$118.96 million

Net margin

-120.86%
NKTR annual net profit margin is -120.86%

Expenses

Total expenses

$228.34M
NKTR annual total expenses is $228.34 million

Operating expenses

$197.66M
NKTR annual total operating expenses is $197.66 million

Cost of goods sold

$30.69M
NKTR annual cost of goods sold is $30.69 million

Selling, general & administrative expenses

$76.75M
NKTR annual SGA is $76.75 million

Depreciation and amortization

$4.39M
NKTR annual depreciation & amortization is $4.39 million

Interest expense

$28.11M
NKTR annual interest expense is $28.11 million

Income tax

-$239.00K
NKTR annual income tax is -$239.00 thousand

EBIT & EBITDA

EBIT

-$91.09M
NKTR annual earnings before interest & taxes is -$91.09 million

EBITDA

-$86.70M
NKTR annual EBITDA is -$86.70 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$303.85M
NKTR annual total assets is $303.85 million

Non current assets

$42.56M
NKTR annual long term assets is $42.56 million

Current assets

$261.29M
NKTR annual total current assets is $261.29 million

Cash and cash equivalents

$44.25M
NKTR annual cash & cash equivalents is $44.25 million

Accounts receivable

$0.00
NKTR annual accounts receivable is $0.00

Inventory

$0.00
NKTR annual inventory is $0.00

Liabilities

Total liabilities

$243.11M
NKTR annual total liabilities is $243.11 million

Long term liabilities

$181.71M
NKTR annual total long term liabilities is $181.71 million

Current liabilities

$61.40M
NKTR annual total current liabilities is $61.40 million

Accounts payable

$11.56M
NKTR annual accounts payable is $11.56 million

Debt

Total debt

$102.56M
NKTR annual total debt is $102.56 million

Total debt 1-year change

-12.92%
NKTR annual total debt is down -12.92% year-on-year

Long term debt

$82.70M
NKTR annual long term debt is $82.70 million

Short term debt

$19.87M
NKTR annual short term debt is $19.87 million

Equity & Capital

Shareholders equity

$60.74M
NKTR annual stockholders equity is $60.74 million

Book value

$60.74M
NKTR annual book value is $60.74 million

Retained earnings

-$3.60B
NKTR annual retained earnings is -$3.60 billion

Working capital

$199.89M
NKTR annual working capital is $199.89 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$175.71M
NKTR annual cash flow from operations is -$175.71 million

Cash from operations 1-year change

+8.77%
NKTR annual cash flow from operations is up +8.77% year-on-year

Cash from investing

$142.57M
NKTR annual cash flow from investing activities is $142.57 million

Cash from investing 1-year change

+2.15%
NKTR annual cash flow from investing activities is up +2.15% year-on-year

Cash from financing

$42.12M
NKTR annual cash flow from financing activities is $42.12 million

Cash from financing 1-year change

+140293.33%
NKTR annual cash flow from financing activities is up +140293.33% year-on-year

CAPEX

CAPEX

$1.47M
NKTR annual capital expenditures is $1.47 million

CAPEX 1-year change

+69.71%
NKTR annual capital expenditures is up +69.71% year-on-year

Free Cash Flow

Free cash flow

-$177.18M
NKTR annual free cash flow is -$177.18 million

Free cash flow 1-year change

+8.42%
NKTR annual free cash flow is up +8.42% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

68.82%
NKTR annual gross profit margin is 68.82%

Operating margin

-131.99%
NKTR annual operating profit margin is -131.99%

Net margin

-120.86%
NKTR annual net profit margin is -120.86%

ROA & ROE

ROA

-33.90%
NKTR annual return on assets is -33.90%

ROE

-124.10%
NKTR annual return on equity is -124.10%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NKTR price to earnings ratio value is unknown

PE ratio Sector rank

-
NKTR price to earnings ratio is unknown

PB Ratio

PB ratio

1.84
NKTR price to book ratio is 1.84

PB ratio Sector rank

60.69%
NKTR price to book ratio is higher than 60.69% of companies in Healthcare sector

PS Ratio

PS ratio

1.14
NKTR price to sales ratio is 1.14

PS ratio Sector rank

29.74%
NKTR price to sales ratio is higher than 29.74% of companies in Healthcare sector

Enterprise value

Enterprise value

$170.03M
NKTR enterprise value is $170.03 million

Enterprise value Sector rank

56.4%
NKTR enterprise value is higher than 56.4% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.96
NKTR EV/EBITDA is -1.96

EV/EBITDA Sector rank

32.15%
NKTR EV/EBITDA is higher than 32.15% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.26
NKTR annual current ratio is 4.26

Quick ratio

4.26
NKTR annual quick ratio is 4.26

Leverage

Debt to equity

0.00
NKTR annual debt to equity ratio is 0.00

Interest coverage ratio

-3.24
NKTR annual interest coverage ratio is -3.24

Risk & Stability

Piotroski F-Score

4
NKTR piotroski f-score is 4

Altman Z-Score

-16.17
NKTR altman z-score is -16.17

Analyst ratings

Recent major analysts updates

Apr 11, 25 Jefferies
Buy
Mar 14, 25 Oppenheimer
Outperform
Mar 13, 25 HC Wainwright & Co.
Buy
Feb 25, 25 HC Wainwright & Co.
Buy
Jan 13, 25 HC Wainwright & Co.
Buy
Jan 8, 25 B. Riley Securities
Buy
Nov 4, 24 Piper Sandler
Overweight
Mar 6, 24 Jefferies
Hold
Nov 9, 23 TD Cowen
Outperform
Aug 7, 23 Mizuho
Neutral

Institutional Ownership

Similar stocks

KOD logo
Kodiak Sciences (KOD)
BTMD logo
biote (BTMD)
LRMR logo
Larimar Therapeutics (LRMR)
ZJYL logo
Jin Medical International (ZJYL)
OBIO logo
Orchestra BioMed Holdings (OBIO)
SCPH logo
scPharmaceuticals (SCPH)
RAPT logo
RAPT Therapeutics (RAPT)
ALDX logo
Aldeyra Therapeutics (ALDX)
BioAge Labs (BIOA)
  • What is the ticker symbol for Nektar Therapeutics?
  • Does Nektar Therapeutics pay dividends?
  • What sector is Nektar Therapeutics in?
  • What industry is Nektar Therapeutics in?
  • What country is Nektar Therapeutics based in?
  • When did Nektar Therapeutics go public?
  • Is Nektar Therapeutics in the S&P 500?
  • Is Nektar Therapeutics in the NASDAQ 100?
  • Is Nektar Therapeutics in the Dow Jones?
  • When was Nektar Therapeutics's last earnings report?
  • When does Nektar Therapeutics report earnings?
  • Should I buy Nektar Therapeutics stock now?

What is the ticker symbol for Nektar Therapeutics?

The ticker symbol for Nektar Therapeutics is NASDAQ:NKTR

Does Nektar Therapeutics pay dividends?

No, Nektar Therapeutics does not pay dividends

What sector is Nektar Therapeutics in?

Nektar Therapeutics is in the Healthcare sector

What industry is Nektar Therapeutics in?

Nektar Therapeutics is in the Biotechnology industry

What country is Nektar Therapeutics based in?

Nektar Therapeutics is headquartered in United States

When did Nektar Therapeutics go public?

Nektar Therapeutics's initial public offering (IPO) was on May 3, 1994

Is Nektar Therapeutics in the S&P 500?

No, Nektar Therapeutics is not included in the S&P 500 index

Is Nektar Therapeutics in the NASDAQ 100?

No, Nektar Therapeutics is not included in the NASDAQ 100 index

Is Nektar Therapeutics in the Dow Jones?

No, Nektar Therapeutics is not included in the Dow Jones index

When was Nektar Therapeutics's last earnings report?

Nektar Therapeutics's most recent earnings report was on Mar 12, 2025

When does Nektar Therapeutics report earnings?

The next expected earnings date for Nektar Therapeutics is May 9, 2025

Should I buy Nektar Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page